Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 9, 2020
Effects of Intravenous Golimumab on Health-Related Quality of Life in Patients With Psoriatic Arthritis: 24-Week Results of the GO-VIBRANT TrialM Elaine Husni, Arthur Kavanaugh, Eric K H Chan, et al.Rheumatology and Therapy|June 15, 2023
Effect of Intravenous Golimumab on Fatigue and the Relationship with Clinical Response in Adults with Active Ankylosing Spondylitis in the Phase 3 GO-ALIVE StudyAtul Deodhar, Natalie J Shiff, Cinty Gong, et al.Journal of Patient-Reported Outcomes|July 29, 2022
Development of a novel patient-reported outcome measure to assess signs and symptoms of COVID-19Carla Romano, Sheri Fehnel, Jeffrey Stoddard, et al.Journal of Clinical Epidemiology|December 22, 2016
Montreal Accord on Patient-Reported Outcomes (PROs) use series-Paper 7: modern perspectives of measurement validation emphasize justification of inferences based on patient reported outcome scoresRichard Sawatzky, Eric K H Chan, Bruno D Zumbo, et al.Clinical Rheumatology|March 3, 2021
The effect of intravenous golimumab on health-related quality of life and work productivity in patients with active psoriatic arthritis: results of the Phase 3 GO-VIBRANT trialAlexis Ogdie, Jessica A Walsh, Soumya D Chakravarty, et al.Journal of Patient-Reported Outcomes|March 4, 2024
A conceptual model for chronic hepatitis B and content validity of the Hepatitis B Quality of Life (HBQOL) instrumentJane Abbott, Natalie V J Aldhouse, Helen Kitchen, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 9, 2020
Effects of Intravenous Golimumab on Health-Related Quality of Life in Patients with Ankylosing Spondylitis: 28-Week Results of the GO-ALIVE TrialJohn D Reveille, Atul Deodhar, Akgun Ince, et al.The New England Journal of Medicine|February 15, 2023
Efficacy and Safety of an Ad26.RSV.preF-RSV preF Protein Vaccine in Older AdultsAnn R Falsey, Kristi Williams, Efi Gymnopoulou, et al.Journal of Patient-Reported Outcomes|May 17, 2023
Psychometric evaluation of the Symptoms of Infection with Coronavirus-19 (SIC): results from a cross-sectional study and a phase 3 clinical trialEric K H Chan, Valerie Williams, Carla Romano, et al.Leukemia & Lymphoma|January 4, 2018
Improvement of fatigue, physical functioning, and well-being among patients with severe impairment at baseline receiving ibrutinib in combination with bendamustine and rituximab for relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma in the HELIOS studyPaula Cramer, Graeme Fraser, Rodrigo Santucci-Silva, et al.Pageof 3